閉経後オステオポローシス(Post Menopausal Osteoporosis):グローバル臨床試験動向(2014年上半期)

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDHC2158CTIDB)
◆英語タイトル:Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC2158CTIDB
◆発行日:2014年5月26日
◆調査対象地域:グローバル
◆ページ数:192
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[閉経後オステオポローシス(Post Menopausal Osteoporosis):グローバル臨床試験動向(2014年上半期)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014

Summary

GlobalData’s clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014″ provides data on the Post Menopausal Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post Menopausal Osteoporosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Post Menopausal Osteoporosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Post Menopausal Osteoporosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Post Menopausal Osteoporosis 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Post Menopausal Osteoporosis Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
F. Hoffmann-La Roche Ltd. 34
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Amgen Inc. 40
Clinical Trial Overview of Amgen Inc. 40
Merck & Co., Inc. 43
Clinical Trial Overview of Merck & Co., Inc. 43
Sanofi 45
Clinical Trial Overview of Sanofi 45
GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
Pfizer Inc. 49
Clinical Trial Overview of Pfizer Inc. 49
Novartis AG 51
Clinical Trial Overview of Novartis AG 51
Radius Health, Inc. 53
Clinical Trial Overview of Radius Health, Inc. 53
Actavis plc 54
Clinical Trial Overview of Actavis plc 54
Clinical Trial Overview of Top Institutes / Government 55
Institut de Recherches Internationales Servier 55
Clinical Trial Overview of Institut de Recherches Internationales Servier 55
University of California, San Francisco 57
Clinical Trial Overview of University of California, San Francisco 57
University of Pittsburgh 58
Clinical Trial Overview of University of Pittsburgh 58
National Institute of Arthritis and Musculoskeletal and Skin Diseases 59
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 59
Mayo Clinic 60
Clinical Trial Overview of Mayo Clinic 60
National Heart, Lung, and Blood Institute 61
Clinical Trial Overview of National Heart, Lung, and Blood Institute 61
Massachusetts General Hospital 62
Clinical Trial Overview of Massachusetts General Hospital 62
National Center for Complementary and Alternative Medicine 63
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 63
Oregon Health and Science University 64
Clinical Trial Overview of Oregon Health and Science University 64
The National Institute of Diabetes and Digestive and Kidney Diseases 65
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 65
Five Key Clinical Profiles 66
Appendix 190
Abbreviations 190
Definitions 190
Research Methodology 191
Secondary Research 191
About GlobalData 192
Contact Us 192
Disclaimer 192
Source 192

List of Tables
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Post Menopausal Osteoporosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Post Menopausal Osteoporosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Post Menopausal Osteoporosis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 34
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 40
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 43
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 45
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 47
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 49
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 51
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radius Health, Inc., 2014* 53
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 54
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2014* 55
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 57
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 58
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 59
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 60
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 61
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 62
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 63
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 64
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 65

List of Figures
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Post Menopausal Osteoporosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 191

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 歯周炎(Periodontitis):治療薬開発パイプライン動向2018
    SUMMARY DelveInsight’s, “ Periodontitis-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Periodontitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical …
  • モーターラミネーションの世界市場予測(~2025年)
    “The increasing stringency in emission norms and fleet level regulations boost the production and sales of EVs which will drive the motor lamination market.”The motor lamination market is estimated to grow from USD 12.6 billion in 2018 to USD 18.6 billion by 2025, at a CAGR of 5.76%. Increase in emi …
  • 鉛蓄電池(自動車)の世界市場2016
    The Global Lead Acid Batteries (Automotive) Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Lead Acid Batteries (Automotive) industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applicati …
  • 世界のイオン交換樹脂市場2016
    Notes:Production, means the output of Ion Exchange Resin Revenue, means the sales value of Ion Exchange Resin This report studies Ion Exchange Resin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capa …
  • 世界及び中国の塩酸市場2017
    The 'Global and Chinese Muriatic Acid Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Muriatic Acid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Muriatic Acid manufactur …
  • Database of Plastic Product Producers(プラスティック製品メーカー調査データ) in Czech Republic – Company Names, Financial Performance, Key Executives, and Contact Details
    The Database of Plastic Product Producers in Czech Republic - Company Names, Financial Performance, Key Executives, and Contact Details offers the most up-to-date perspective on plastic product producers in Czech Republic. The report includes details for more than 200 plastic product producers in Cz …
  • 世界及び中国のキャビア市場2017
    The 'Global and Chinese Caviar Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Caviar industry with a focus on the Chinese market. The report provides key statistics on the market status of the Caviar manufacturers and is a valuable …
  • DPWH – NAIA Expressway Phase II Development – Philippines – 建設プロジェクト概要
    WMI's DPWH - NAIA Expressway Phase II Development - Philippines - Construction Project Profile is a crucial resource for industry executives and anyone looking to access key information about the NAIA Expressway Phase II Development construction project. WMI's DPWH - NAIA Expressway Phase II Develop …
  • OncoTherapy Science, Inc. (4564)(製薬・医療分野):企業M&A動向
    Summary OncoTherapy Science, Inc. (OncoTherapy) is a biotechnology company. The company discovers and develops antibody drugs. Its products under clinical development include C01, OTSGC-A24, S-488410, S-288310, S-488210, OTS102, OCV-101, ONO-7268MX1, OCV-103/104, NCV01, OTSA101 and OTS167. OncoThera …
  • タイの鉄道インフラ建設市場(~2019)
    This report is the result of Timetric’s extensive market research covering the rail infrastructure construction industry in Thailand. It contains detailed historic and forecast market value data for the rail infrastructure construction industry, including a breakdown of the data by construction acti …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC2158CTIDB )"閉経後オステオポローシス(Post Menopausal Osteoporosis):グローバル臨床試験動向(2014年上半期)" (英文:Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。